Via EDGAR Submission


November 16, 2020


Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549


Re:IN8bio, Inc. (the “Company”)
Registration Statement on Form S-1 (File No. 333-249530)


Ladies and Gentlemen:


As the Representative of the several underwriters of the Company’s proposed initial public offering of common stock, we respectfully withdraw our request for acceleration of the effectiveness of the Registration Statement on Form S-1 (File No. 333-249530), set forth in a letter dated November 9, 2020.


[Remainder of Page Intentionally Left Blank]





Very truly yours,




By:/s/ Victoria Hale  
 Name: Victoria Hale  
 Title: Authorized Signatory  


As Representative of the several underwriters.


cc: Nathan Ajiashvili, Partner, Latham & Watkins LLP


[Signature Page to Acceleration Withdrawal Request]